The role of particle size distribution on bioavailability of cyclosporine: novel drug delivery system.

Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia

Volumn 145, Issue 2, 2001, Pages 3-8

  Andrysek T ^a  

^a TEVA PHARMACEUTICALS   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; BIOAVAILABILITY; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; HUMAN; MALE; PARTICLE SIZE; PHARMACOKINETICS; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL;

ADULT; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PARTICLE SIZE; PILOT PROJECTS; THERAPEUTIC EQUIVALENCY;

EID: 0035747331     PISSN: 12138118     EISSN: None     Source Type: Journal    
DOI: 10.5507/bp.2001.006     Document Type: Article

References (0)